SGX203 - Oral BDP for Treating Pediatric Crohn’s Disease - Soligenix

SGX203 is specifically formulated for oral administration as a single product consisting of two tablets. One tablet releases BDP in the upper gastrointestinal (GI) tract and the other tablet releases BDP in the lower GI tract.


We have initiated the SGX203 development program for pediatric Crohn’s disease. The objective of developing SGX203 for pediatric Crohn’s is to make available a corticosteroid option with less toxicity than the current standard therapy prednisone.

SGX203 in pediatric Crohn’s disease has been awarded Orphan Drug and Fast Track Designations by the FDA.

About Pediatric Crohn’s Disease

Crohn’s disease is a chronic disorder that can cause inflammation of any part of the gastrointestinal tract. It most commonly affects the lower part of the small intestine called the ileum. The inflammation associated with the disease extends deep into the lining of the intestine and is typically associated with pain and diarrhea.

Though Crohn’s disease can appear at any age, it is most often diagnosed in young adults in their 20s and 30s. Approximately 30% of people with Crohn’s disease develop symptoms before 20 years of age. Pediatric Crohn’s disease affects approximately 80,000 patients in the United States.  Crohn’s disease tends to be both severe and extensive in the pediatric population with a relatively high proportion (~40-50%) of pediatric Crohn’s patients having involvement of their upper GI tract, proximal to the ileum. Crohn’s disease presents special challenges for children and teens as the disease can stunt growth, delay puberty, and weaken bones.

Current therapy for pediatric Crohn’s disease consists of off-label use of systemic corticosteroids such as prednisone, immunosuppressive drugs such as 6-mercaptopurine and methotrexate and biologics such as Remicade®. Of these, only Remicade® is approved with an indication for treatment of children with moderately to severely active disease who have had an inadequate response to conventional therapy.

Try to ensure there will be no hidden costs that might sometimes be imposed by certain companies, such as the fees for some additional services or some other extra expenses. This will allow you to be fully confident that you will not have to pay any extra cash. The above-mentioned points indicate that there are many risks associated with purchasing drugs from online companies, although it still remains a highly convenient way to get what you need timely and without unwanted trouble. Additional Facts about Buying Drugs from Online Above all, you should ensure that you are guaranteed timely delivery, especially if you need your drugs to be delivered to you as soon as possible. Sometimes, there might be certain restrictions imposed by the border protection services, which might result in the untimely delivery of your drugs. Nevertheless, it is always better to take the necessary precautions in advance by contacting the company whose services you are using and letting them know that you need to get your medications without delays. This is especially vital if you have never used the services of the chosen drugstore before and do not know much about their reliability.